COVID-19: Edo civil servants get 7-day ultimatum to get vaccinated
Civil servants in the Edo Ministry of Health have been given a seven-day ultimatum to get vaccinated against the COVID-19 pandemic. The ultimatum was contained in a memo dated Aug.…
Civil servants in the Edo Ministry of Health have been given a seven-day ultimatum to get vaccinated against the COVID-19 pandemic. The ultimatum was contained in a memo dated Aug.…
People who get the Delta variant of the coronavirus are twice as likely to be hospitalised as those who were infected by the Alpha variant which was first detected in…
People wait in line to be vaccinated in Sydney, Australia, August 25, 2021. REUTERS/Loren Elliott/File Photo Here is a summary of some recent studies on COVID-19. They include research that…
Vials with a sticker reading, “COVID-19 / Coronavirus vaccine / Injection only” and a medical syringe are seen in front of a displayed Moderna logo in this illustration taken October…
People are twice as likely to need hospital care if they are sick with the Delta Covid variant, rather than the Alpha variant that was once prevalent in the UK,…
Covid -19 vaccine booster shots will be made widely available to Americans in September, while several other countries including Israel, Germany and France have decided to offer boosters to older…
Protection against COVID-19 offered by two doses of the Pfizer/BioNTech and the Oxford/AstraZeneca coronavirus vaccines begins to fade within six months, underscoring the need for booster shots, according to researchers…
An Israeli, 40+-year-old woman, receives her booster shot REUTERS/Ammar Awad/ Less than a month into a Covid -19 vaccine booster drive, Israel is seeing signs of an impact on the…
A third dose of Pfizer (PFE.N)‘s Covid-19 vaccine has significantly improved protection from infection and serious illness among people aged 60 and older in Israel compared with those who received…
A health worker prepares a bed for Covid-19 patients AstraZeneca’s new antibody therapy reduced the risk of people developing COVID-19 symptoms by 77% in a late-stage trial, putting the drugmaker…